| Historic (1865-12-01 to
2009-12-20) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
MC2R
|
16 |
208.5 |
  |
| 2 |
ACTH
|
16 |
167.6 |
  |
| 3 |
MC2
|
10 |
138.6 |
  |
| 4 |
protein
|
19 |
106.1 |
  |
| 5 |
MRAP2
|
7 |
97.8 |
  |
| 6 |
familial glucocorticoid deficiency
|
6 |
86.4 |
  |
| 7 |
AAAS
|
5 |
76.2 |
  |
| 8 |
computed tomography with arterial portography
|
4 |
61.4 |
  |
| 9 |
RAMP3
|
4 |
56.8 |
  |
| 10 |
MPAP
|
3 |
47.3 |
  |
| 11 |
melanocortin-2
|
3 |
44.4 |
  |
| 12 |
LDYI
|
3 |
42.6 |
  |
| 13 |
MR
|
3 |
36.5 |
  |
| 14 |
hypoplasia
|
3 |
34.1 |
  |
| 15 |
ALADIN
|
2 |
33.4 |
  |
|
| 10 years (1999-12-23 to
2009-12-20) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
MC2R
|
16 |
196.0 |
  |
| 2 |
ACTH
|
16 |
155.0 |
  |
| 3 |
MC2
|
10 |
130.8 |
  |
| 4 |
MRAP2
|
7 |
92.3 |
  |
| 5 |
protein
|
18 |
86.9 |
  |
| 6 |
familial glucocorticoid deficiency
|
6 |
81.7 |
  |
| 7 |
AAAS
|
5 |
72.3 |
  |
| 8 |
RAMP3
|
4 |
53.7 |
  |
| 9 |
melanocortin-2
|
3 |
42.1 |
  |
| 10 |
LDYI
|
3 |
40.2 |
  |
| 11 |
ALADIN
|
2 |
31.8 |
  |
| 12 |
maximal squeeze anal pressures
|
2 |
31.8 |
  |
| 13 |
hypoplasia
|
3 |
31.7 |
  |
| 14 |
POMC
|
2 |
30.4 |
  |
| 15 |
PC1
|
2 |
28.8 |
  |
|
|